Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
D006018:Glycols / Q000627:therapeutic use*; D008620:Meprobamate; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009497:Neurotic Disorders / Q000628:therapy*; D019946:Propylene Glycol; D011409:Propylene Glycols; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000628:therapy*; D014149:Tranquilizing Agents
D006018:Glycols; D009125:Muscle Relaxants, Central; D011409:Propylene Glycols; D014149:Tranquilizing Agents; C041787:1,3-propanediol; D019946:Propylene Glycol; D008620:Meprobamate
GLYCOLS/therapeutic use; MUSCLE RELAXANTS/therapeutic use; NEUROSES/therapy; PSYCHOSES/therapy